Patients with neuroendocrine tumours may be treated in a variety of manners, depending on the disease type, severity and extension. Treatment options include surgery, systemic chemotherapy, transarterial chemoembolisation, radionuclide treatment as well as symptomatic/palliative treatment.
The liver is a usual site of neuroendocrine tumour metastases; in such cases there is medical indication for transarterial chemoembolisation or – if there are few metastatic lesions of relatively small size – radiofrequency ablation.
Dr Ioannis Dedes has been successfully performing transarterial chemoembolisations and ablations of liver metastases originating from neuroendocrine tumours at the Interbalkan Medical Centre for more than 10 years.